News2 mins ago
ADDF STATEMENT ON FDA ADVISORY COMMITTEE’S ENDORSEMENT OF LECANEMAB (LEQEMBI)
The FDA Advisory Committee’s endorsement of Leqembi ushers in a new era for Alzheimer’s therapeutics Anti-amyloids are not the panacea, underscoring the need to develop novel...